Neuroprotective function of dj-1 in Parkinson's disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Ariga, Hiroyoshi ^a   Takahashi Niki, Kazuko ^a   Kato, Izumi ^a   Maita, Hiroshi ^a   Niki, Takeshi ^a   Iguchi Ariga, Sanae M M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; ANTI-OXIDATIVE STRESS; ENVIRONMENTAL FACTORS; MITOCHONDRIAL DYSFUNCTION; NEURODEGENERATION; PARKINSON'S DISEASE; TRANSCRIPTIONAL REGULATION; VARIOUS FUNCTIONS;

AMINO ACIDS; GENES; OXIDATIVE STRESS; SENSORS;

NEURODEGENERATIVE DISEASES;

CHAPERONE; DJ 1 PROTEIN; DOPAMINE; PROTEINASE; NEUROPROTECTIVE AGENT; ONCOPROTEIN;

DOPAMINE METABOLISM; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; DOPAMINE; HUMANS; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 84878709844     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/683920     Document Type: Review

References (117)

1. Hauser D. N., Hastings T. G., Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiology of Disease 2013 51 35 42 10.1016/j.nbd.2012.10.011
2. Sai Y., Zou Z., Peng K., Dong Z., The Parkinson's disease-related genes act in mitochondrial homeostasis. Neuroscience & Biobehavioral Reviews 2012 36 9 2034 2043 10.1016/j.neubiorev.2012.06.007
3. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S. M. M., Ariga H., DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochemical and Biophysical Research Communications 1997 231 2 509 513 2-s2.0-0031566231 10.1006/bbrc.1997.6132 (Pubitemid 27214343)
4. Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., van Dongen J. W., Vanacore N., van Swieten J. C., Brice A., Meco G., van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003 299 5604 256 259 2-s2.0-0037428241 10.1126/science.1077209 (Pubitemid 36131051)
5. Honbou K., Suzuki N. N., Horiuchi M., Niki T., Taira T., Ariga H., Inagaki F., The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. The Journal of Biological Chemistry 2003 278 33 31380 31384 2-s2.0-0042232029 10.1074/jbc.M305878200 (Pubitemid 36994658)
6. Tao X., Tong L., Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. The Journal of Biological Chemistry 2003 278 33 31372 31379 2-s2.0-0042232039 10.1074/jbc.M304221200 (Pubitemid 36994657)
7. Lee S. J., Kim S. J., Kim I. K., Ko J., Jeong C. S., Kim G. H., Park C., Kang S. O., Suh P. G., Lee H. S., Cha S. S., Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. The Journal of Biological Chemistry 2003 278 45 44552 44559 2-s2.0-0242497815 10.1074/jbc.M304517200 (Pubitemid 37377208)
8. Wilson M. A., Collins J. L., Hod Y., Ringe D., Petsko G. A., The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9256 9261 2-s2.0-0042130551 10.1073/pnas.1133288100 (Pubitemid 37033916)
9. Huai Q., Sun Y., Wang H., Chin L. S., Li L., Robinson H., Ke H., Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. The FEBS Letters 2003 549 1-3 171 175 2-s2.0-0042063899 10.1016/S0014-5793(03)00764-6 (Pubitemid 36959865)
10. Bandyopadhyay S., Cookson M. R., Evolutionary and functional relationships within the DJ1 superfamily. BMC Evolutionary Biology 2004 4, article 6 2-s2.0-2942589064 10.1186/1471-2148-4-6 (Pubitemid 38761944)
11. Du X., Choi I. G., Kim R., Wang W., Jancarik J., Yokota H., Kim S. H., Crystal structure of an intracellular protease from Pyrococcus horikoshii at 2-Å resolution. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14079 14084 2-s2.0-0034687746 10.1073/pnas.260503597 (Pubitemid 32016533)
12. Rizzu P., Hinkle D. A., Zhukareva V., Bonifati V., Severijnen L. A., Martinez D., Ravid R., Kamphorst W., Eberwine J. H., Lee V. M. Y., Trojanowski J. Q., Heutink P., DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Annals of Neurology 2004 55 1 113 118 2-s2.0-9144257938 10.1002/ana.10782 (Pubitemid 38067368)
13. Yanagida T., Takata K., Inden M., Kitamura Y., Taniguchi T., Yoshimoto K., Taira T., Ariga H., Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain. Journal of Pharmacological Sciences 2006 102 2 243 247 2-s2.0-33750614959 10.1254/jphs.SC0060098 (Pubitemid 44690983)
14. Yanagida T., Tsushima J., Kitamura Y., Yanagisawa D., Takata K., Shibaike T., Yamamoto A., Taniguchi T., Yasui H., Taira T., Morikawa S., Inubushi T., Tooyama I., Ariga H., Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxidative Medicine and Cellular Longevity 2009 2 1 36 42 2-s2.0-67649644282
15. Bandopadhyay R., Kingsbury A. E., Cookson M. R., Reid A. R., Evans I. M., Hope A. D., Pittman A. M., Lashley T., Canet-Aviles R., Miller D. W., McLendon C., Strand C., Leonard A. J., Abou-Sleiman P. M., Healy D. G., Ariga H., Wood N. W., De Silva R., Revesz T., Hardy J. A., Lees A. J., The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 2004 127 part 2 420 430 2-s2.0-10744224738 10.1093/brain/awh054 (Pubitemid 38160326)
16. Neumann M., Müller V., Görner K., Kretzschmar H. A., Haass C., Kahle P. J., Pathological properties of the Parkinson's disease-associated protein DJ-1 in α -synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathologica 2004 107 6 489 496 2-s2.0-2942689352 10.1007/s00401-004-0834-2 (Pubitemid 38765389)
17. Mullett S. J., Hamilton R. L., Hinkle D. A., DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age. Neuropathology 2009 29 2 125 131 2-s2.0-62749199149 10.1111/j.1440-1789.2008. 00955.x
18. Waak J., Weber S. S., Waldenmaier A., Görner K., Alunni-Fabbroni M., Schell H., Vogt-Weisenhorn D., Pham T. T., Reumers V., Baekelandt V., Wurst W., Kahle P. J., Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. The FASEB Journal 2009 23 8 2478 2489 2-s2.0-68849097924 10.1096/fj.08-125153
19. Mullett S. J., Hinkle D. A., DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity. Journal of Neurochemistry 2011 117 3 375 387 2-s2.0-79953903691 10.1111/j.1471-4159.2011. 07175.x
20. Larsen N. J., Ambrosi G., Mullett S. J., Berman S. B., Hinkle D. A., DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 2011 196 251 264 10.1016/j.neuroscience.2011.08.016
21. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S. M. M., Ariga H., DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. The Journal of Biological Chemistry 2001 276 40 37556 37563 2-s2.0-0035813135 10.1074/jbc.M101730200
22. Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S. M. M., Ariga H., DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Molecular Cancer Research 2003 1 4 247 261 2-s2.0-0037291493 (Pubitemid 36292610)
23. Shinbo Y., Taira T., Niki T., Iguchi-Ariga S. M., Ariga H., DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. International Journal of Oncology 2005 26 3 641 648 2-s2.0-18144420749
24. Xu J., Zhong N., Wang H., Elias J. E., Kim C. Y., Woldman I., Pifl C., Gygi S. P., Geula C., Yankner B. A., The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Human Molecular Genetics 2005 14 9 1231 1241 2-s2.0-20944437573 10.1093/hmg/ddi134 (Pubitemid 40613911)
25. Zhong N., Kim C. Y., Rizzu P., Geula C., Porter D. R., Pothos E. N., Squitieri F., Heutink P., Xu J., DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. The Journal of Biological Chemistry 2006 281 30 20940 20948 2-s2.0-33746355607 10.1074/jbc.M601935200 (Pubitemid 44115435)
26. Clements C. M., McNally R. S., Conti B. J., Mak T. W., Ting J. P. Y., DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proceedings of the National Academy of Sciences of the United States of America 2006 103 41 15091 15096 2-s2.0-33750052885 10.1073/pnas.0607260103 (Pubitemid 44583169)
27. Tillman J. E., Yuan J., Gu G., Fazli L., Ghosh R., Flynt A. S., Gleave M., Rennie P. S., Kasper S., DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Research 2007 67 10 4630 4637 2-s2.0-34250357109 10.1158/0008-5472.CAN-06-4556 (Pubitemid 46910167)
28. Fan J., Ren H., Fei E., Jia N., Ying Z., Jiang P., Wu M., Wang G., Sumoylation is critical for DJ-1 to repress p53 transcriptional activity. The FEBS Letters 2008 582 7 1151 1156 2-s2.0-40849123844 10.1016/j.febslet.2008.03. 003
29. Ishikawa S., Taira T., Takahashi-Niki K., Niki T., Ariga H., Iguchi-Ariga S. M. M., Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. The Journal of Biological Chemistry 2010 285 51 39718 39731 2-s2.0-78650065962 10.1074/jbc.M110.137034
30. Mitsumoto A., Nakagawa Y., Takeuchi A., Okawa K., Iwamatsu A., Takanezawa Y., Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radical Research 2001 35 3 301 310 2-s2.0-0034906096 (Pubitemid 32734231)
31. Yokota T., Sugawara K., Ito K., Takahashi R., Ariga H., Mizusawa H., Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochemical and Biophysical Research Communications 2003 312 4 1342 1348 2-s2.0-0345357664 10.1016/j.bbrc.2003.11.056 (Pubitemid 37490964)
32. Taira T., Saito Y., Niki T., Iguchi-Ariga S. M. M., Takahashi K., Ariga H., DJ-1 has a role in antioxidative stress to prevent cell death. The EMBO Reports 2004 5 2 213 218 2-s2.0-1642527499 10.1038/sj.embor.7400074 (Pubitemid 38401204)
33. Canet-Avilés R. M., Wilson M. A., Miller D. W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M. J., Ringe D., Petsko G. A., Cookson M. R., The Parkinson's disease DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proceedings of the National Academy of Sciences of the United States of America 2004 101 24 9103 9108 2-s2.0-2942684871 10.1073/pnas.0402959101 (Pubitemid 38781618)
34. Kinumi T., Kimata J., Taira T., Ariga H., Niki E., Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 2004 317 3 722 728 2-s2.0-1842740232 10.1016/j.bbrc.2004.03.110 (Pubitemid 38481432)
35. Martinat C., Shendelman S., Jonason A., Leete T., Beal M. F., Yang L., Floss T., Abeliovich A., Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS Biology 2004 2 11, article e327 2-s2.0-13944279784 10.1371/journal.pbio.0020327 (Pubitemid 40280475)
36. Inden M., Taira T., Kitamura Y., Yanagida T., Tsuchiya D., Takata K., Yanagisawa D., Nishimura K., Taniguchi T., Kiso Y., Yoshimoto K., Agatsuma T., Koide-Yoshida S., Iguchi-Ariga S. M. M., Shimohama S., Ariga H., PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiology of Disease 2006 24 1 144 158 2-s2.0-33748765225 10.1016/j.nbd.2006.06.004 (Pubitemid 44416214)
37. Shendelman S., Jonason A., Martinat C., Leete T., Abeliovich A., DJ-1 Is a redox-dependent molecular chaperone that inhibits α -synuclein aggregate formation. PLoS Biology 2004 2 11, article e362 2-s2.0-13944267769 10.1371/journal.pbio.0020362 (Pubitemid 40280476)
38. Zhou W., Zhu M., Wilson M. A., Petsko G. A., Fink A. L., The oxidation state of DJ-1 regulates its chaperone activity toward α -synuclein. Journal of Molecular Biology 2006 356 4 1036 1048 2-s2.0-31344464179 10.1016/j.jmb.2005.12.030 (Pubitemid 43145955)
39. Olzmann J. A., Brown K., Wilkinson K. D., Rees H. D., Huai Q., Ke H., Levey A. I., Li L., Chin L. S., Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. The Journal of Biological Chemistry 2004 279 9 8506 8515 2-s2.0-1542349213 10.1074/jbc.M311017200 (Pubitemid 38294744)
40. Koide-Yoshida S., Niki T., Ueda M., Himeno S., Taira T., Iguchi-Ariga S. M. M., Ando Y., Ariga H., DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy. International Journal of Molecular Medicine 2007 19 6 885 893 2-s2.0-34548598264
41. Chen J., Li L., Chin L. S., Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage. Human Molecular Genetics 2010 19 12 2395 2408 2-s2.0-77955287253 10.1093/hmg/ddq113
42. Ooe H., Taira T., Iguchi-Ariga S. M. M., Ariga H., Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicological Sciences 2005 88 1 114 126 2-s2.0-27644542366 10.1093/toxsci/kfi278 (Pubitemid 41548753)
43. Li H. M., Niki T., Taira T., Iguchi-Ariga S. M. M., Ariga H., Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radical Research 2005 39 10 1091 1099 2-s2.0-25444514752 10.1080/10715760500260348 (Pubitemid 41358563)
44. Junn E., Jang W. H., Zhao X., Jeong B. S., Mouradian M. M., Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. Journal of Neuroscience Research 2009 87 1 123 129 2-s2.0-63049138430 10.1002/jnr.21831
45. Hayashi T., Ishimori C., Takahashi-Niki K., Taira T., Kim Y. C., Maita H., Maita C., Ariga H., Iguchi-Ariga S. M. M., DJ-1 binds to mitochondrial complex I and maintains its activity. Biochemical and Biophysical Research Communications 2009 390 3 667 672 2-s2.0-70449729372 10.1016/j.bbrc.2009.10.025
46. Irrcher I., Aleyasin H., Seifert E. L., Hewitt S. J., Chhabra S., Phillips M., Lutz A. K., Rousseaux M. W. C., Bevilacqua L., Jahani-Asl A., Callaghan S., MacLaurin J. G., Winklhofer K. F., Rizzu P., Rippstein P., Kim R. H., Chen C. X., Fon E. A., Slack R. S., Harper M. E., McBride H. M., Mak T. W., Park D. S., Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Human Molecular Genetics 2010 19 19 3734 3746 2-s2.0-77956522541 10.1093/hmg/ddq288
47. Hao L. Y., Giasson B. I., Bonini N. M., DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proceedings of the National Academy of Sciences of the United States of America 2010 107 21 9747 9752 2-s2.0-77953084081 10.1073/pnas.0911175107
48. Krebiehl G., Ruckerbauer S., Burbulla L. F., Kieper N., Maurer B., Waak J., Wolburg H., Gizatullina Z., Gellerich F. N., Woitalla D., Riess O., Kahle P. J., Proikas-Cezanne T., Krüger R., Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS ONE 2010 5 2 2-s2.0-77949623516 10.1371/journal.pone.0009367 e9367
49. Ren H., Fu K., Wang D., Mu C., Wang G., Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL. The Journal of Biological Chemistry 2011 286 40 35308 35317 10.1074/jbc.M110.207134
50. Thomas K. J., McCoy M. K., Blackinton J., Beilina A., van der Brug M., Sandebring A., Miller D., Maric D., Cedazo-Minguez A., Cookson M. R., DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Human Molecular Genetics 2011 20 1 40 50 2-s2.0-79956323688
51. Wang X., Petrie T. G., Liu Y., Liu J., Fujioka H., Zhu X., Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. Journal of Neurochemistry 2012 121 5 830 839 10.1111/j.1471-4159.2012.07734.x
52. Heo J. Y., Park J. H., Kim S. J., DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly. PLoS One 2012 7 3, article e32629
53. Wagenfeld A., Gromoll J., Cooper T. G., Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochemical and Biophysical Research Communications 1998 251 2 545 549 2-s2.0-0032552851 10.1006/bbrc.1998.9512 (Pubitemid 28505059)
54. Welch J. E., Barbee R. R., Roberts N. L., Suarez J. D., Klinefelter G. R., Breakthrough in andrology: Sp22: a novel fertility protein from a highly conserved gene family. Journal of Andrology 1998 19 4 385 393 2-s2.0-0032112350 (Pubitemid 28397121)
55. Le Naour F., Misek D. E., Krause M. C., Deneux L., Giordano T. J., Scholl S., Hanash S. M., Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clinical Cancer Research 2001 7 11 3328 3335 2-s2.0-0035187302 (Pubitemid 33069962)
56. Allard L., Burkhard P. R., Lescuyer P., Burgess J. A., Walter N., Hocnstrasser D. F., Sanchez J. C., PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clinical Chemistry 2005 51 11 2043 2051 2-s2.0-27444437764 10.1373/clinchem.2005.053942 (Pubitemid 41532619)
57. Waragai M., Wei J., Fujita M., Nakai M., Ho G. J., Masliah E., Akatsu H., Yamada T., Hashimoto M., Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochemical and Biophysical Research Communications 2006 345 3 967 972 2-s2.0-33646833404 10.1016/j.bbrc.2006.05.011 (Pubitemid 43776502)
58. Waragai M., Nakai M., Wei J., Fujita M., Mizuno H., Ho G., Masliah E., Akatsu H., Yokochi F., Hashimoto M., Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neuroscience Letters 2007 425 1 18 22 2-s2.0-34548645355 10.1016/j.neulet.2007.08.010 (Pubitemid 47410359)
59. Maita C., Tsuji S., Yabe I., Hamada S., Ogata A., Maita H., Iguchi-Ariga S. M. M., Sasaki H., Ariga H., Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neuroscience Letters 2008 431 1 86 89 2-s2.0-38049011407 10.1016/j.neulet.2007.11.027
60. Tsuboi Y., Munemoto H., Ishikawa S., Matsumoto K. I., Iguchi-Ariga S. M. M., Ariga H., DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. The FEBS Letters 2008 582 17 2643 2649 2-s2.0-46749086971 10.1016/j.febslet.2008.06.043
61. Kim S. J., Park Y. J., Hwang I. Y., Youdim M. B., Park K. S., Oh Y. J., Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death. Free Radical Biology & Medicine 2012 53 4 936 950 10.1016/j.freeradbiomed.2012.05.035
62. Choi J., Sullards M. C., Olzmann J. A., Rees H. D., Weintraub S. T., Bostwick D. E., Gearing M., Levey A. I., Chin L. S., Li L., Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. The Journal of Biological Chemistry 2006 281 16 10816 10824 2-s2.0-33646826619 10.1074/jbc.M509079200 (Pubitemid 43855504)
63. Mitsumoto A., Nakagawa Y., DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radical Research 2001 35 6 885 893 2-s2.0-0035692636 (Pubitemid 34065677)
64. Lucas J. I., Marín I., A new evolutionary paradigm for the Parkinson disease gene DJ-1. Molecular Biology and Evolution 2007 24 2 551 561 2-s2.0-33846849338 10.1093/molbev/msl186 (Pubitemid 46204387)
65. Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C., Seino C., Iguchi-Ariga S. M. M., Ariga H., Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death and Differentiation 2006 13 1 96 108 2-s2.0-33645002036 10.1038/sj.cdd.4401704
66. Ito G., Ariga H., Nakagawa Y., Iwatsubo T., Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Biochemical and Biophysical Research Communications 2006 339 2 667 672 2-s2.0-28444433110 10.1016/j.bbrc.2005.11.058 (Pubitemid 41739719)
67. Rahman-Roblick R., Hellman U., Becker S., Bader F. G., Auer G., Wiman K. G., Roblick U. J., Proteomic identification of p53-dependent protein phosphorylation. Oncogene 2008 27 35 4854 4859 2-s2.0-49649099031 10.1038/onc.2008.124
68. Yamaguchi S., Yamane T., Takahashi-Niki K., Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis. PLoS One 2012 7 5, article e38144
69. Fan J., Ren H., Jia N., Fei E., Zhou T., Jiang P., Wu M., Wang G., DJ-1 decreases Bax expression through repressing p53 transcriptional activity. The Journal of Biological Chemistry 2008 283 7 4022 4030 2-s2.0-40849138195 10.1074/jbc.M707176200
70. Kato I., Maita H., Takahashi-Niki K., Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner. Molecular and Cellular Biology 2013 33 2 340 359 10.1128/MCB.01350-12
71. Nishinaga H., Takahashi-Niki K., Taira T., Andreadis A., Iguchi-Ariga S. M. M., Ariga H., Expression profiles of genes in DJ-1-knockdown and L166P DJ-1 mutant cells. Neuroscience Letters 2005 390 1 54 59 2-s2.0-24944560479 10.1016/j.neulet.2005.07.053 (Pubitemid 41317789)
72. Zhou W., Freed C. R., DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T α -synuclein toxicity. The Journal of Biological Chemistry 2005 280 52 43150 43158 2-s2.0-30044449754 10.1074/jbc.M507124200 (Pubitemid 43049281)
73. Goldberg M. S., Pisani A., Haburcak M., Vortherms T. A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B. L., Pothos E. N., Calabresi P., Shen J., Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1. Neuron 2005 45 4 489 496 2-s2.0-13844253723 10.1016/j.neuron.2005.01.041 (Pubitemid 40249861)
74. Kim R. H., Smith P. D., Aleyasin H., Hayley S., Mount M. P., Pownall S., Wakeham A., You-Ten A. J., Kalia S. K., Horne P., Westaway D., Lozano A. M., Anisman H., Park D. S., Mak T. W., Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5215 5220 2-s2.0-20144389422 10.1073/pnas.0501282102
75. Chen L., Cagniard B., Mathews T., Jones S., Koh H. C., Ding Y., Carvey P. M., Ling Z., Kang U. J., Zhuang X., Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. The Journal of Biological Chemistry 2005 280 22 21418 21426 2-s2.0-20444367300 10.1074/jbc.M413955200 (Pubitemid 40805706)
76. Ishikawa S., Taira T., Niki T., Takahashi-Niki K., Maita C., Maita H., Ariga H., Iguchi-Ariga S. M. M., Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. The Journal of Biological Chemistry 2009 284 42 28832 28844 2-s2.0-70350399505 10.1074/jbc.M109.019950
77. Ishikawa S., Tanaka Y., Takahashi-Niki K., Niki T., Ariga H., Iguchi-Ariga S. M. M., Stimulation of vesicular monoamine transporter 2 activity by DJ-1 in SH-SY5Y cells. Biochemical and Biophysical Research Communications 2012 421 4 813 818 10.1016/j.bbrc.2012.04.095
78. Yotsumoto F., Sanui A., Fukami T., Shirota K., Horiuchi S., Tsujioka H., Yoshizato T., Kuroki M., Miyamoto S., Efficacy of ligand-based targeting for the EGF system in cancer. Anticancer Research 2009 29 11 4879 4885 2-s2.0-75149129578
79. Takeuchi K., Ito F., EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS Journal 2010 277 2 316 326 2-s2.0-74549193993 10.1111/j.1742-4658.2009.07450.x
80. Kim R. H., Peters M., Jang Y., DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005 7 3 263 273 10.1016/j.ccr.2005.02.010 (Pubitemid 40568685)
81. Kim Y. C., Kitaura H., Taira T., Iguchi-Ariga S. M. M., Ariga H., Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. International Journal of Oncology 2009 35 6 1331 1341 2-s2.0-73949097658 10.3892/ijo-00000451
82. Tang B., Xiong H., Sun P., Zhang Y., Wang D., Hu Z., Zhu Z., Ma H., Pan Q., Xia J. H., Xia K., Zhang Z., Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Human Molecular Genetics 2006 15 11 1816 1825 2-s2.0-33744760852 10.1093/hmg/ddl104 (Pubitemid 43821772)
83. Hattori K., Naguro I., Runchel C., Ichijo H., The roles of ASK family proteins in stress responses and diseases. Cell Communication and Signaling 2009 7 article 9 10.1186/1478-811X-7-9
84. Shiizaki S., Naguro I., Ichijo H., Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling. Advances in Biological Regulation 2013 53 1 135 144
85. Iriyama T., Takeda K., Nakamura H., Morimoto Y., Kuroiwa T., Mizukami J., Umeda T., Noguchi T., Naguro I., Nishitoh H., Saegusa K., Tobiume K., Homma T., Shimada Y., Tsuda H., Aiko S., Imoto I., Inazawa J., Chida K., Kamei Y., Kozuma S., Taketani Y., Matsuzawa A., Ichijo H., ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. The EMBO Journal 2009 28 7 843 853 2-s2.0-65449146296 10.1038/emboj.2009.32
86. Benhar M., Engelberg D., Levitzki A., ROS, stress-activated kinases and stress signaling in cancer. The EMBO Reports 2002 3 5 420 425 2-s2.0-0035984912 10.1093/embo-reports/kvf094 (Pubitemid 34567428)
87. Thandavarayan R. A., Watanabe K., Ma M., Veeraveedu P. T., Gurusamy N., Palaniyandi S. S., Zhang S., Muslin A. J., Kodama M., Aizawa Y., 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochemical Pharmacology 2008 75 9 1797 1806 2-s2.0-41949122949 10.1016/j.bcp.2008.02.003
88. Yamamoto E., Dong Y. F., Kataoka K., Yamashita T., Tokutomi Y., Matsuba S., Ichijo H., Ogawa H., Kim-Mitsuyama S., Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating Kinase-1 inhibition. Hypertension 2008 52 3 573 580 2-s2.0-52049105198 10.1161/HYPERTENSIONAHA.108.112292
89. Izumiya Y., Kim S., Izumi Y., Yoshida K., Yoshiyama M., Matsuzawa A., Ichijo H., Iwao H., Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodelling. Circulation Research 2003 93 9 874 883 2-s2.0-0242266963 10.1161/01.RES.0000100665.67510.F5 (Pubitemid 37363062)
90. Yamaguchi O., Higuchi Y., Hirotani S., Kashiwase K., Nakayama H., Hikoso S., Takeda T., Watanabe T., Asahi M., Taniike M., Matsumura Y., Tsujimoto I., Hongo K., Kusakari Y., Kurihara S., Nishida K., Ichijo H., Hori M., Otsu K., Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15883 15888 2-s2.0-9144231898 10.1073/pnas.2136717100 (Pubitemid 38021084)
91. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H., ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes & Development 2002 16 11 1345 1355 2-s2.0-0036606540 10.1101/gad.992302 (Pubitemid 34615088)
92. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., Ichijo H., ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes & Development 2008 22 11 1451 1464 2-s2.0-44849124411 10.1101/gad.1640108 (Pubitemid 351793080)
93. Kadowaki H., Nishitoh H., Urano F., Sadamitsu C., Matsuzawa A., Takeda K., Masutani H., Yodoi J., Urano Y., Nagano T., Ichijo H., Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death and Differentiation 2005 12 1 19 24 2-s2.0-19944426148 10.1038/sj.cdd.4401528 (Pubitemid 40090025)
94. Abou-Sleiman P. M., Healy D. G., Quinn N., Lees A. J., Wood N. W., The role of pathogenic DJ-1 mutations in Parkinson's disease. Annals of Neurology 2003 54 3 283 286 2-s2.0-0042232353 10.1002/ana.10675 (Pubitemid 37072030)
95. Hering R., Strauss K. M., Tao X., Bauer A., Woitalla D., Mietz E. M., Petrovic S., Bauer P., Schaible W., Müller T., Schöls L., Klein C., Berg D., Meyer P. T., Schulz J. B., Wollnik B., Tong L., Krüger R., Riess O., Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Human Mutation 2004 24 4 321 329 2-s2.0-5044235807 10.1002/humu.20089 (Pubitemid 39336638)
96. Aleyasin H., Rousseaux M. W. C., Phillips M., Kim R. H., Bland R. J., Callaghan S., Slack R. S., During M. J., Mak T. W., Park D. S., The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18748 18753 2-s2.0-36749013055 10.1073/pnas.0709379104 (Pubitemid 350210768)
97. Yanagisawa D., Kitamura Y., Inden M., Takata K., Taniguchi T., Morikawa S., Morita M., Inubushi T., Tooyama I., Taira T., Iguchi-Ariga S. M. M., Akaike A., Ariga H., DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. Journal of Cerebral Blood Flow and Metabolism 2008 28 3 563 578 2-s2.0-39749124831 10.1038/sj.jcbfm.9600553 (Pubitemid 351304267)
98. Malhotra D., Thimmulappa R., Navas-Acien A., Sandford A., Elliott M., Singh A., Chen L., Zhuang X., Hogg J., Pare P., Tuder R. M., Biswal S., Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. American Journal of Respiratory and Critical Care Medicine 2008 178 6 592 604 2-s2.0-51849129227 10.1164/rccm.200803-380OC
99. Jain D., Jain R., Eberhard D., Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. Journal of Molecular Cell Biology 2012 4 4 221 230 10.1093/jmcb/mjs025
100. Junn E., Taniguchi H., Jeong B. S., Zhao X., Ichijo H., Mouradian M. M., Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9691 9696 2-s2.0-22144465488 10.1073/pnas.0409635102 (Pubitemid 40981742)
101. Karunakaran S., Diwakar L., Saeed U., Agarwal V., Ramakrishnan S., Iyengar S., Ravindranath V., Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α -lipoic acid. The FASEB Journal 2007 21 9 2226 2236 2-s2.0-34347369328 10.1096/fj.06-7580com (Pubitemid 47026457)
102. Waak J., Weber S. S., Görner K., Schall C., Ichijo H., Stehle T., Kahle P. J., Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. The Journal of Biological Chemistry 2009 284 21 14245 14257 2-s2.0-67649771389 10.1074/jbc.M806902200
103. Lev N., Ickowicz D., Barhum Y., Lev S., Melamed E., Offen D., DJ-1 protects against dopamine toxicity. Journal of Neural Transmission 2009 116 2 151 160 2-s2.0-59849104963 10.1007/s00702-008-0134-4
104. Aron L., Klein P., Pham T. T., Kramer E. R., Wurst W., Klein R., Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. PLoS Biology 2010 8 4, article e1000349 2-s2.0-77951756407 10.1371/journal.pbio.1000349
105. Gao H., Yang W., Qi Z., DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy. Journal of Molecular Biology 2012 423 2 232 248 10.1016/j.jmb.2012.06.034
106. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kawaga Y., Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochemical and Biophysical Research Communications 1989 163 3 1450 1455 2-s2.0-0024330311 (Pubitemid 19244751)
107. Parker W. D. Jr., Boyson S. J., Parks J. K., Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of Neurology 1989 26 6 719 723 2-s2.0-0024848034 10.1002/ana.410260606 (Pubitemid 20011004)
108. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D., Mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurochemistry 1990 54 3 823 827 2-s2.0-0025254401
109. Orth M., Schapira A. H. V., Mitochondrial involvement in Parkinson's disease. Neurochemistry International 2002 40 6 533 541 2-s2.0-0036182026 10.1016/S0197-0186(01)00124-3 (Pubitemid 34159154)
110. Mizuno Y., Yoshino H., Ikebe S. I., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T., Mitochondrial dysfunction in Parkinson's disease. Annals of Neurology 1998 44 3 S99 S109 2-s2.0-0031711713 (Pubitemid 28423835)
111. Giaime E., Yamaguchi H., Gautier C. A., Kitada T., Shen J., Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening. PLoS One 2012 7 7, aricle e40501
112. Zhang L., Shimoji M., Thomas B., Moore D. J., Yu S. W., Marupudi N. I., Torp R., Torgner I. A., Ottersen O. P., Dawson T. M., Dawson V. L., Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Human Molecular Genetics 2005 14 14 2063 2073 2-s2.0-24944534660 10.1093/hmg/ddi211 (Pubitemid 41418042)
113. Maita C., Maita H., Iguchi-Ariga S. M. M., Ariga H., Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants. PLoS One 2013 8 1, article e54087
114. de Mena L., Coto E., Sánchez-Ferrero E., Ribacoba R., Guisasola L. M., Salvador C., Blázquez M., Alvarez V., Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease. Journal of Neural Transmission 2009 116 10 1289 1293 2-s2.0-70349238601 10.1007/s00702-009-0273-2
115. Miyazaki S., Yanagida T., Nunome K., Ishikawa S., Inden M., Kitamura Y., Nakagawa S., Taira T., Hirota K., Niwa M., Iguchi-Ariga S. M. M., Ariga H., DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. Journal of Neurochemistry 2008 105 6 2418 2434 2-s2.0-44649091944 10.1111/j.1471-4159.2008.05327.x (Pubitemid 351782268)
116. Kitamura Y., Watanabe S., Taguchi M., Takagi K., Kawata T., Takahashi-Niki K., Yasui H., Maita H., Iguchi-Ariga S. M., Ariga H., Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats. Molecular Neurodegeneration 2011 6 1, article 48 2-s2.0-79959973394 10.1186/1750-1326-6-48
117. Inden M., Kitamura Y., Takahashi K., Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Journal of Pharmacological Sciences 2011 117 3 189 203 10.1254/jphs.11151FP